Eversana Intouch, a prominent biopharma services company in the United States, is taking a significant step by acquiring its long-standing partner, Healthware Group, based in Europe. This strategic move is designed to enhance Eversana’s service offerings and expand its global presence.
Headquartered in Salerno, Italy, Healthware is a full-service agency and consultancy with a rich history of collaboration with Eversana dating back to 2017. The acquisition is expected to have an immediate impact on Eversana’s operations in Europe and its global capabilities. It aims to assist pharmaceutical, medical device, and emerging biotech companies worldwide in product launches, expanding market access, and addressing unique geographical and market-specific challenges.
Healthware’s comprehensive services encompass marketing, advisory, customer engagement, media services, medical communications, and education. Although the financial specifics of the deal remain undisclosed, it is anticipated that the integration of artificial intelligence into marketing strategies, a concept referred to as “pharmatizing,” will be a significant part of this collaboration.
Also Read: Eversana And Amazon Are Planning An AI-Driven Drug Push
In addition to Healthware, Eversana also gains the assets of pharmaphorum, a pharma industry media group based in the United Kingdom, as part of this acquisition.
“Today’s announcement is the next remarkable step in our journey to reinvent commercialisation by effectively integrating what we believe to be the best service providers around the world. Gone are the days of siloed, ineffective operations or regional strategies. Our clients need global strategy and integrated commercial services balanced with the right in-market expertise. And now with an even stronger global agency powerhouse connected to Eversana’s full commercial ecosystem, we are advancing our commitment to provide clients with unmatched support for brands worldwide.”
– Jim Lang, CEO, Eversana
Eversana’s recent recognition at Cannes Lions, where it received a gold award for The Chrysalis Initiative focused on addressing disparities in breast cancer, underscores its dedication to making a positive impact in the healthcare and pharma landscape. This acquisition positions Eversana as a formidable player in the global healthcare market, equipped to provide a wide array of services and expertise to its clients.
